Feyisayo (Sayo) Eweje
Feyisayo (Sayo) Eweje| Wyss Institute
Elliot is Chairman of the Roberta and Stephen R. Weiner Department of Surgery and Surgeon-in-Chief at Beth Israel Deaconess Medical Center (BIDMC). Dr. Chaikof has promoted alliances of clinicians, engineers, chemists, and biologists and in the process developed biologically-inspired materials, devices, and pharmacotherapeutics based upon the principles of molecular engineering and nanofabrication technologies. These endeavors...| Wyss Institute
Every year the Wyss Institute names a class of Validation Projects whose teams receive dedicated funding, business development support, and other resources to advance their promising technologies towards commercialization. They also collaborate with key opinion leaders, investors, and potential customers to de-risk their innovations and speed their progress to the market. This year, we’re thrilled...| Wyss Institute
Browse photos from our community, inspired by science, technology, and Nature| Wyss InstituteWyss Institute
New stem cell differentiation method is first to induce meiosis, a critical step in egg and sperm cell development, with potential for drug development and future fertility treatments| Wyss InstituteWyss Institute
Throughout recent years, the Wyss’ Validation Project mechanism has proven to be a highly valuable instrument for selecting and kick-starting projects with early potential for positive impact on healthcare and the environment. Reaching deep into areas with major unmet needs across the diverse Grand Challenges laid out by the Institute, the newly selected projects are...| Wyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Anastasia Ershova loves fencing because every opponent is a new puzzle to solve, and both fencers are constantly engaged, making adjustments based on each...| Wyss Institute
AI-enabled drug discovery approach identified potentially game-changing treatment, which has been advanced from the lab bench to an FDA Orphan Drug Designation in record time| Wyss InstituteWyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. In 2018, Sanjid Shahriar started developing two new skills: powerlifting and computational biology. Each was started with an initial goal of complementing things he already possessed…| Wyss InstituteWyss Institute
Patient-matched Organ Chips mimicking the tumor microenvironment can effectively personalize chemotherapy selection in cancer patients| Wyss InstituteWyss Institute
New Wyss Catalyst Embraces AI Landscape to Advance Innovation and Collaboration| Wyss InstituteWyss Institute
Last month, the Wyss Institute had the honor of hosting the Women’s Health Access Matters (WHAM) Spring Forum, convening researchers, industry leaders, investors, and advocates committed to closing the gender health gap. The event brought together cross-sector voices to explore bold ideas, share scientific breakthroughs, and catalyze action across women’s brain, heart, and reproductive health....| Wyss Institute
As he battles metastatic skin cancer, Wyss Scientific Instrument Maker John Caramanica is more motivated than ever to do his part in fabricating technologies to improve the health of others and our planet| Wyss InstituteWyss Institute
By Benjamin Boettner (BOSTON) — Microglia are a specialized type of immune cells that accounts for about 10% of all cells within the brain and spinal cord. They function by eliminating infectious microbes, dead cells, and aggregated proteins, as well as soluble antigens that may endanger the brain and, during development, also help shape neural...| Wyss Institute
The Problem Infectious diseases have plagued humanity for millennia, and the pathogens that infect and sicken humans are constantly evolving. Severe infections can cause sepsis, a life-threatening condition in which a patient’s immune system overreacts to the infection. The body starts to attack itself, which can lead to tissue damage, organ failure, and death. Sepsis...| Wyss Institute
Handheld electrochemical sensors have revolutionized at-home medical testing for diabetics, but they have not yet been successfully applied to diagnosing other conditions. These sensors are based on the activity of an enzyme, and there are only a limited number of enzymes that can be used to detect biomarkers of human disease. An alternative, much more...| Wyss Institute
By Benjamin Boettner (BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute’s eRapid technology with the company’s proprietary transistor sensor technology to...| Wyss Institute
News COVID drug developed through AI-enabled modeling| Wyss Institute
At the Wyss Institute, we have a long history of celebrating the intersection of science and art, drawing inspiration from what we see in the lab and outside in Nature. The art world has recognized this connection too, with Wyss work featured in exhibits at Cooper Hewitt, MoMA, and the Barbican Centre. To continue honoring...| Wyss Institute
By Alexandra Jirstrand (BOSTON) – The Wyss Institute at Harvard University, its Board of Directors, and Executive Leadership are pleased to announce that Natalie Artzi, Ph.D., has been appointed to a newly created position as Associate Institute Director of the Wyss Institute. In her new role, Artzi will work closely with the Wyss Founding Director...| Wyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Sayo Eweje loves finding solutions, whether he’s looking at a Rubik’s Cube or a technical challenge in the lab. When faced with the problem...| Wyss Institute
By Lindsay Brownell (BOSTON) — Getting medicines into the cells they’re designed to treat is a perennial problem for the medicine and pharmaceutical industries, and patients often suffer from side effects and ineffective treatments as a result. Current drug delivery vehicles carry a host of risks and limits: lipid nanoparticles can cause immune reactions and...| Wyss Institute
This op-ed originally appeared in MedPage Today. By Donald Ingber, M.D., Ph.D. I was on the frontlines when COVID-19 hit and it felt like a surprise attack. Many academic research departments closed, but the Wyss Institute at Harvard, which I head, moved into high gear. We raced to develop new ways to manufacture nasal swabs,...| Wyss Institute
By Don Ingber Credit: Wyss Institute at Harvard University On April 11, we at the Wyss Institute welcomed more than 550 researchers, industry leaders, physicians, and entrepreneurs to our Annual Retreat in which we shared the amazing progress our community has made in the development of new bioinspired diagnostics, devices, and therapeutics for both human...| Wyss Institute
Donald E. Ingber, M.D., Ph.D., is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, and Hansjörg Wyss Professor of Biologically Inspired Engineering at the Harvard John A. Paulson School of...| Wyss Institute
By Benjamin Boettner This video explains the basic principles of eRapid as an electrochemical sensing platform, and how it could be used for low-cost, multiplexed detection of a wide range of biomolecules for diagnostic applications. Credit: Wyss Institute at Harvard University (BOSTON) – In an article published in the prestigious Accounts in Chemical Research, Wyss...| Wyss Institute
Michael Levin, a Distinguished Professor in the Biology department at Tufts, holds the Vannevar Bush endowed Chair and serves as director of the Allen Discovery Center at Tufts and the Tufts Center for Regenerative and Developmental Biology. Recent honors include the Scientist of Vision award and the Distinguished Scholar Award. His group’s focus is on understanding...| Wyss Institute
Study suggests a pain relief drug that can quickly and reversibly induce a sleep-like state in cells and organs could facilitate organ transplantation and prevent irreversible tissue injury| Wyss Institute
Wyss Institute’s Biostasis team advances science right on schedule| Wyss Institute
